Bank of America reissued a buy rating and Morgan Stanley lifted the price target for Royalty Pharma.

The entities involved

• Bank of America →

  American multinational banking and financial services corporation

  • Bank of America acquired a new position in Caterpillar stock, while Wyoming adjusted its stake and major banks maintained 'buy' ratings.14:11
  • CFE, Mexico's state power company, is conducting an international sale deal coordinated by Santander and Bank of America.10:03
• Royalty Pharma →

  biopharmaceutical company based in New York City

  • Royalty Pharma acquired a royalty interest in Amgen's drug Imdelltra.Sat 18:11
  • Royalty Pharma is investing in drug makers and developers to diversify its portfolio in the biotech sector.Sun 15:42
• Morgan Stanley →

  U.S. investment bank

  • Trust Group reduced its stock holdings in Morgan Stanley on November 1, 2026.12:10
  • A peace deal is discussed, with terms constraining Israel's objectives and aiming to reopen the Strait of Hormuz.10:13

Related events

• Bank of America issued a buy rating on the stock of Parabilis Medicines on October 16, 2026.Oct 16
• Royal Bank of Canada, Bank of America, and Morgan Stanley issued various rating and price target updates.Oct 20
• Bank of America set a buy rating and price target for Penguin Solutions on October 23, 2026.Oct 24
• Royal Bank of Canada, Bank of America, and Morgan Stanley raised price targets for argenex.Jul 7
• Royal Bank of Canada, Citigroup, and Morgan Stanley issued price target and rating updates on August 27, 2026.Aug 27